| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Peter McNamara | Chief Scientific Officer | 2026-03-06 | 215 | $35.00 | $7.53kSell |
| Peter McNamara | Chief Scientific Officer | 2026-03-06 | 6,047 | $30.00 | $181.41kSell |
| Marcella K. Ruddy | Chief Medical Officer | 2026-03-06 | 10,000 | $30.00 | $300.00kSell |
| Peter McNamara | Chief Scientific Officer | 2026-03-06 | 215 | $14.71 | $3.16kBuy |
| Peter McNamara | Chief Scientific Officer | 2026-03-06 | 2,500 | $2.38 | $5.95kBuy |
| Peter McNamara | Chief Scientific Officer | 2026-03-04 | 1,650 | $25.00 | $41.25kSell |
| Peter McNamara | Chief Scientific Officer | 2026-03-03 | 1,649 | $22.06 | $36.38kSell |
| Alise Reicin | Chief Executive Officer | 2026-02-11 | 2,500 | $21.10 | $52.75kBuy |
| Alise Reicin | Chief Executive Officer | 2026-02-11 | 2,500 | $21.10 | $52.75kBuy |
| Daniel Lochner | Chief Financial Officer | 2026-02-10 | 6,000 | $21.61 | $129.66kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Timothy A. Springer | 32.08% | 6,024,338 | $180.01M | Insider |
| Bruce Booth | 29.65% | 5,567,289 | $166.35M | Insider |
| Braden Michael Leonard | 26.12% | 4,905,068 | $146.56M | Insider |
| Atlas Venture Fund X LP | 25.33% | 4,756,478 | $142.12M | Insider |
| Clarus Lifesciences III LP | 23.66% | 4,443,487 | $132.77M | Insider |
| Atlas Venture Associates X LP | 19.76% | 3,710,052 | $110.86M | Insider |
| Blackstone Holdings II LP | 15.78% | 2,962,325 | $88.51M | Insider |
| Scott Requadt | 15.78% | 2,962,325 | $88.51M | Insider |
| Fmr LLC | 14.95% | 2,807,442 | $83.89M | Institution |
| Aberdeen Group PLC | 6.08% | 1,141,824 | $34.12M | Institution |